论文部分内容阅读
目的:探讨多巴胺联合酚妥拉明治疗小儿重症肺炎的治疗方法与治疗效果。方法:在2014年6月~2015年6月期间我院接受治疗的重症肺炎患儿中选取50例,由患儿不同的治疗方法将其分为观察组与对照组各25例,我院为对照组患儿提供止咳、雾化吸入、抗感染等常规治疗,给予观察组患儿采用多巴胺联合酚妥拉明治疗,比较两组患儿治疗效果、住院时间以及临床表现持续时间、治疗后的不良反应。结果:观察组患儿治疗总有效率为96%,明显高于对照组患儿治疗总有效的80%,P<0.05,在咳嗽、气促等主要的临床症状持续时间的比较上,观察组患儿持续时间少于对照组,且住院时间也较短,P<0.05。两组患儿不良反应发生率接近,无统计意义,P>0.05。结论:采用多巴胺与酚妥拉明联合治疗小儿重症肺炎疾病,具有很好的治疗效果,缩短住院时间,安全可靠,具有很高的临床应用价值。
Objective: To investigate the therapeutic and therapeutic effects of dopamine and phentolamine in children with severe pneumonia. Methods: From June 2014 to June 2015, 50 children with severe pneumonia admitted to our hospital were enrolled and divided into observation group and control group with 25 cases by different treatment methods. Control children with cough, inhalation, anti-infection and other conventional treatment, given observation group of children treated with dopamine combined with phentolamine, the treatment effect of two groups of children, hospital stay and clinical duration, after treatment Adverse reactions. Results: The total effective rate of treatment group was 96% in observation group, which was significantly higher than that in control group (80%, P <0.05). On the comparison of the main clinical symptoms such as cough and shortness of breath, Duration of children less than the control group, and shorter hospital stay, P <0.05. Two groups of children with adverse reactions close to the rate, no statistical significance, P> 0.05. Conclusion: The combination of dopamine and phentolamine in the treatment of severe pneumonia in children has good curative effect, shortened hospitalization time, safe and reliable, and has high clinical value.